Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant573 active trials4 approved drugs14 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,386 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04534075 | Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial(FIDURA) | completed | Phase 3 | 354 | Sahlgrenska University HospitalOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT04646005 | Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy | completed | Phase 2 | 113 | Regeneron PharmaceuticalsINDUSTRY | 8 |
| Sep 8, 2025 |
| clinicaltrials |
| NCT00924027 | A Study of Patients Receiving High-Dose Rate Brachytherapy | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 5, 2025 | clinicaltrials |
| NCT05742711 | Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients | completed | N/A | 48 | DyAnsys, Inc.INDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT03898167 | Prospective Evaluation of Self-Testing to Increase Screening(PRESTIS) | completed | N/A | 2,474 | Baylor College of MedicineOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT03300557 | Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2025 | clinicaltrials |
| NCT04772989 | A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies(ARC-12) | completed | Phase 1 | 94 | Arcus Biosciences, Inc.INDUSTRY | 3 | Aug 28, 2025 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT05105087 | Gynecological Sentinel Lymph Nodes CEUS | completed | Early Phase 1 | 9 | Thomas Jefferson UniversityOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT06958068 | Sexual Health Integration in Treatment of Gynecological Oncology(SHIFT-GO) | completed | — | 324 | Medical University of SilesiaOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT03748186 | Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers | completed | Phase 1 | 136 | Sutro Biopharma, Inc.INDUSTRY | 2 | Aug 20, 2025 | clinicaltrials |
| NCT06165614 | Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya | completed | Phase 1 | 17 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT06263582 | Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya | completed | Phase 1 | 12 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT04092257 | HPV-Based Screen-and-Treat Demonstration Project in Lilongwe | completed | N/A | 1,250 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT03728881 | Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial(PRIMAVERA) | completed | Phase 3 | 1,240 | National Cancer Institute (NCI)NIH | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06048367 | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor(CNSI-Fe(II)) | completed | Phase 1 | 19 | Sichuan Enray Pharmaceutical Sciences CompanyOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT00092534 | Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)(FUTURE II) | completed | Phase 3 | 12,167 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 1, 2025 | clinicaltrials |
| NCT04458597 | Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. | completed | N/A | 23 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT03104699 | A Study of AGEN2034 in Advanced Tumors and Cervical Cancer | completed | Phase 1 / Phase 2 | 211 | Agenus Inc.INDUSTRY | 9 | Jul 30, 2025 | clinicaltrials |
| NCT03444376 | The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer | completed | Phase 1 / Phase 2 | 65 | Genexine, Inc.INDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT03086681 | Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma(ECWHCCFLACC) | completed | Phase 2 | 120 | Yong Zhang,MDOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT04788849 | Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples(Ext-VALHUDES) | completed | — | 300 | University of Milano BicoccaOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT07070687 | Transcutaneous Electrical Nerve Stimulation in Nerve-Sparing Radical Hysterectomy: Effects on Bladder Management and Quality of Life in Cervical Cancer | completed | N/A | 78 | Fudan UniversityOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT04242199 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors | completed | Phase 1 | 182 | Incyte CorporationINDUSTRY | 5 | Jul 14, 2025 | clinicaltrials |
| NCT05453006 | HPV Self-Sampling in Somali Women (Isbaar Project)(Isbaar) | completed | N/A | 3,367 | University of MinnesotaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT02635360 | Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer | completed | Phase 2 | 94 | Linda R DuskaOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT04461678 | Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit | completed | N/A | 12,230 | Becton, Dickinson and CompanyINDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT01226316 | Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules | completed | Phase 1 | 285 | AstraZenecaINDUSTRY | 10 | Jun 29, 2025 | clinicaltrials |
| NCT06054841 | Reshaping Postpartum Follow-up | completed | N/A | 157 | Medstar Health Research InstituteOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT04694495 | HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study | completed | — | 7,500 | Zhujiang HospitalOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT03357757 | Avelumab With Valproic Acid in Virus-associated Cancer(LATENT) | completed | Phase 2 | 39 | AHS Cancer Control AlbertaOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT04998318 | 1:1 Comparison of the Pocket Colposcope in Kenya | completed | N/A | 434 | Duke UniversityOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT01351103 | A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands | completed | Phase 1 | 185 | Novartis PharmaceuticalsINDUSTRY | 7 | Jun 13, 2025 | clinicaltrials |
| NCT03542513 | First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN) | completed | — | 65 | Universiteit AntwerpenOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT03826589 | Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy(ALARICE) | completed | N/A | 23 | The University of Hong KongOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05939440 | Interventions to Decrease Financial Toxicity(P-COC) | completed | N/A | 60 | University of Alabama at BirminghamOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT03108131 | Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT02713386 | Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 / Phase 2 | 147 | NRG OncologyOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT03994055 | Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer | completed | N/A | 136 | National Institute of CancerologíaOTHER_GOV | 1 | May 25, 2025 | clinicaltrials |
| NCT01101451 | Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery | completed | Phase 3 | 340 | GOG FoundationNETWORK | 3 | May 23, 2025 | clinicaltrials |
| NCT03508570 | Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis | completed | Phase 1 | 26 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06984289 | US Radiomics in Advanced Cervical Cancer(RU-LACC) | completed | — | 220 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06284447 | Barriers to Cervical Cancer Screening | completed | — | 2,216 | Mayo ClinicOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06562595 | What is the Optimal Training Model for Cervical Awareness? | completed | N/A | 400 | Izmir City HospitalOTHER_GOV | 1 | May 20, 2025 | clinicaltrials |
| NCT03198286 | Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors | completed | N/A | 40 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT04821297 | Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results | completed | N/A | 30 | Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT02487095 | Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers | completed | Phase 1 / Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Apr 13, 2025 | clinicaltrials |
| NCT03196180 | Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia | completed | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06915779 | Long Term Follow-up of HPV Vaccine in HIV (CTN 236) | completed | — | 241 | University of British ColumbiaOTHER | 1 | Apr 8, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Sep 8, 2025source: clinicaltrials